comparemela.com
Latest Breaking News On - Targeted therapeutic technology - Page 1 : comparemela.com
Regel Therapeutics announces its participation at the Dravet Syndrome Conference and attendance at the European Dravet Syndrome Advanced Therapies Meeting in Madrid, Spain on March 23rd and 24th 2023.
/PRNewswire/ Regel Therapeutics, a next generation gene therapy company utilizing proprietary technology to develop clinical products modulating gene.
Berkeley
California
United-states
Cambridge
Cambridgeshire
United-kingdom
Jordane-dimidschstein
Navneet-matharu
Broad-institute
Regel-therapeutics-inc
Therapeutic-technology
Dravet-conference-meeting
Regel Therapeutics details its proprietary T3 platform and development pipeline on its newly launched website, expands its Board of Directors and announces its Scientific Advisory Board.
/PRNewswire/ Regel Therapeutics, a next generation gene therapy company utilizing proprietary technology to develop clinical products modulating gene.
Berkeley
California
United-states
Cambridge
Cambridgeshire
United-kingdom
San-francisco
Wendy-chung
Orrin-devinsky
Steve-ruchefsky
Andrew-schiermeier
Nadav-ahituv
vimarsana © 2020. All Rights Reserved.